Tysabri failure in stroke a setback for BiogenBiogen’s hopes that one of its established multiple sclerosis drugs might also help stroke sufferers have been dashed. Share XTysabri failure in stroke a setback for Biogenhttps://pharmaphorum.com/news/tysabri-failure-stroke-setback-biogen/
